Prevalence and determinants of elevated apolipoprotein B and dense low-density lipoprotein in youths with type 1 and type 2 diabetes.

OBJECTIVE The objective of the study was to assess the prevalence and determinants of elevated apolipoprotein B (apoB) and dense low-density lipoprotein (LDL) in United States youth with type 1 or type 2 diabetes. METHODS We conducted cross-sectional analyses of apoB concentrations, LDL density, and prevalence of elevated apoB levels and dense LDL from the SEARCH for Diabetes in Youth study, a six-center U.S.-based study of youth with diabetes onset younger than 20 years of age (2657 with type 1 and 345 with type 2). RESULTS Among youth with type 1 diabetes, 11% had elevated apoB (>or=100 mg/dl, 1.95 mm/liter), 8% had dense LDL (relative flotation rate<or=0.237), and 12% had elevated LDL-cholesterol (>or=130 mg/dl, 3.36 mm/liter). In contrast, among youth with type 2 diabetes, 36% had elevated apoB, 36% had dense LDL, but only 23% had elevated LDL-cholesterol. Dense LDL and apoB each increased with hemoglobin A1c in both types. Among type 1 diabetics in poor glycemic control (hemoglobin A1c>or=9.5%), 28% had elevated apoB, and 18% had dense LDL, whereas 72% of poorly controlled type 2 diabetics had elevated apoB and 62% had dense LDL. CONCLUSIONS In youth with type 1 diabetes, elevated apoB and dense LDL were not highly prevalent, whereas elevated apoB and dense LDL were common lipoprotein abnormalities in youth with type 2 diabetes. The prevalence of these risk factors substantially increased with poor glycemic control in both groups, stressing the importance of achieving and maintaining an optimal glucose control.

[1]  J. Silverstein,et al.  Type 2 diabetes in children and adolescents , 2003, Pediatric diabetes.

[2]  S. Daniels,et al.  Serum lipids and glucose control: the SEARCH for Diabetes in Youth study. , 2007, Archives of pediatrics & adolescent medicine.

[3]  I. D. de Boer,et al.  Gender and elevated albumin excretion in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort: role of central obesity. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  Nader Rifai,et al.  Non–High-Density Lipoprotein Cholesterol and Apolipoprotein B in the Prediction of Coronary Heart Disease in Men , 2005, Circulation.

[5]  P. Libby,et al.  Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. , 2005, Circulation.

[6]  Zahi A Fayad,et al.  Risk scores predict atherosclerotic lesions in young people. , 2005, Archives of internal medicine.

[7]  G. Dagenais,et al.  Low-Density Lipoprotein Subfractions and the Long-Term Risk of Ischemic Heart Disease in Men: 13-Year Follow-Up Data From the Québec Cardiovascular Study , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[8]  F. Kaufman,et al.  Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. , 2004, The Journal of pediatrics.

[9]  SEARCH for Diabetes in Youth: a multicenter study of the prevalence, incidence and classification of diabetes mellitus in youth. , 2004, Controlled clinical trials.

[10]  D. Atkins,et al.  American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. , 2003, Circulation.

[11]  Paul T. Williams,et al.  Smallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[12]  Management of dyslipidemia in children and adolescents with diabetes. , 2003, Diabetes care.

[13]  D. Freedman,et al.  Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. , 2002, The American journal of cardiology.

[14]  I. Holme,et al.  High apolipoprotein B, low apolipoprotein A-1, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study☆ , 2002 .

[15]  J. Frohlich,et al.  Hypertriglyceridemic hyperapoB in type 2 diabetes. , 2002, Diabetes care.

[16]  Terho Lehtimäki,et al.  Carotid artery intima-media thickness in children with type 1 diabetes. , 2002, Diabetes.

[17]  I. Holme,et al.  High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study , 2001, The Lancet.

[18]  C. Berne.  Diabetes mellitus – a more solid ground for treatment , 2001, Journal of internal medicine.

[19]  M. Laakso,et al.  Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention , 2001, Journal of internal medicine.

[20]  J. Strong,et al.  Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[21]  A. Wägner,et al.  Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients. , 1999, Diabetes care.

[22]  P A Cleary,et al.  Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial. , 1998, JAMA.

[23]  M. Austin,et al.  Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes , 1996, Current opinion in lipidology.

[24]  S. Marcovina,et al.  Evidence that Lp[a] contains one molecule of apo[a] and one molecule of apoB: evaluation of amino acid analysis data. , 1996, Journal of lipid research.

[25]  P. Wilson,et al.  Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. , 1996, Clinical chemistry.

[26]  J. Hokanson,et al.  Levels of Lipoprotein(a), Apolipoprotein B, and Lipoprotein Cholesterol Distribution in IDDM: Results From Follow-Up in the Diabetes Control and Complications Trial , 1995, Diabetes.

[27]  M. Koschinsky,et al.  Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). , 1995, Clinical chemistry.

[28]  W. H. Hannon,et al.  International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference Material. , 1993, Clinical chemistry.

[29]  G. Watts,et al.  Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). , 1993, Metabolism: clinical and experimental.

[30]  R. Krauss,et al.  LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[31]  M. Taskinen.  Quantitative and Qualitative Lipoprotein Abnormalities in Diabetes Mellitus , 1992, Diabetes.

[32]  M. Taskinen.  3 Hyperlipidaemia in diabetes , 1990 .

[33]  J. Hokanson,et al.  Large Buoyant LDL‐like Particles in Hepatic Lipase Deficiency , 1989, Arteriosclerosis.

[34]  M. Taskinen,et al.  Insulin Therapy Induces Antiatherogenic Changes of Serum Lipoproteins in Noninsulin‐Dependent Diabetes , 1988, Arteriosclerosis.

[35]  B. Howard,et al.  Lipoprotein metabolism in diabetes mellitus. , 1987, Journal of lipid research.

[36]  L. Rand,et al.  Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. , 1987, The American journal of cardiology.

[37]  G. Gibbons,et al.  Hyperlipidaemia of diabetes. , 1986, Clinical science.

[38]  P. Wahl,et al.  Lipoprotein quantification: an electrophoretic method compared with the Lipid Research Clinics method. , 1982, Clinical chemistry.

[39]  W. Hazzard,et al.  Lp(a) lipoprotein: relationship to sinking pre-beta lipoprotein hyperlipoproteinemia, and apolipoprotein B. , 1975, Metabolism: clinical and experimental.